慢性肾脏病患者中非酒精性脂肪性肝病的患病率:横断面研究
在291例CKD患者与866例年龄性别匹配的正常肾功能对照中,CT评估的中重度肝脂肪变患病率分别为7.9%和10.7%(P=0.177),CKD分期与肝脂肪含量无关。合并分析显示糖尿病、超重和肥胖者中重度肝脂肪变的校正OR分别为3.1、14.8和42.0。
要点
- CKD患者中重度肝脂肪变患病率与正常肾功能人群无显著差异。
- CKD分期与肝脂肪含量无关联。
- 糖尿病、超重和肥胖是中重度肝脂肪变的独立危险因素。
核心结论
- 在291例CKD患者中,肾功能与CT评估的中重度肝脂肪变患病率无关。
研究设计与样本
- 横断面研究,纳入Copenhagen CKD队列291例患者及866例年龄性别匹配的正常肾功能对照。
- 采用CT扫描评估肝脂肪含量,以肝衰减密度<48 HU定义中重度肝脂肪变。
主要发现
- 中重度肝脂肪变患病率在CKD组为7.9%,对照组为10.7%(P=0.177)。
- 未发现肝脂肪含量与CKD分期之间的关联。
- 合并数据集中,糖尿病、超重和肥胖者中重度肝脂肪变的校正OR分别为3.1(95%CI 1.6-5.9)、14.8(95%CI 4.6-47.9)和42.0(95%CI 12.9-136.6)。
临床怎么用
- CKD患者中重度肝脂肪变并不少见,可考虑对合并糖尿病、超重或肥胖者进行肝脂肪评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease and represents a wide spectrum ranging from mild steatosis to non-alcoholic steatohepatitis with or without fibrosis to overt cirrhosis. Patients with NAFLD have a high risk of developing cardiovascular disease and chronic kidney disease (CKD). So far there has been scarce evidence of the prevalence of NAFLD among patients with CKD. We investigated the prevalence of moderate-severe hepatic steatosis graded according to the definition of NAFLD in a cohort of patients with CKD. METHODS: Hepatic liver fat content was evaluated by computed tomography (CT) scan in 291 patients from the Copenhagen CKD Cohort Study and in 866 age- and sex-matched individuals with normal kidney function from the Copenhagen General Population Study. Liver attenuation density <48 HU was used as a cut-off value for moderate-severe hepatic steatosis. RESULTS: The prevalence of moderate-severe hepatic steatosis was 7.9 and 10.7% (P = 0.177) among patients with CKD and controls, respectively. No association between liver fat content and CKD stage was found. In the pooled dataset from both cohorts, adjusted odds ratios for moderate-severe hepatic steatosis among persons with diabetes, overweight and obesity were 3.1 [95% confidence interval (CI) 1.6-5.9], 14.8 (95% CI 4.6-47.9) and 42.0 (95% CI 12.9-136.6), respectively. CONCLUSIONS: In a cohort of 291 patients with CKD, kidney function was not associated with the prevalence of moderate-severe hepatic steatosis as assessed by CT scan.
引用
- Adrian T, Sørensen IMH, Knop FK, et al. Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a cross-sectional study. Nephrol Dial Transplant. 2022. PMID: 34505899. doi:10.1093/ndt/gfab266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。